OrthogenRx

OrthogenRx, Inc. is a medical device company based in Doylestown, Pennsylvania, dedicated to developing and commercializing treatments for knee pain caused by osteoarthritis (OA). The company focuses on creating safe and effective orthopedic medical devices, particularly targeting OA knee pain. OrthogenRx offers a range of class-III orthopedic medical devices designed to provide treatment options for patients suffering from knee osteoarthritis. The company emphasizes affordable healthcare products with fair pricing, ethical business practices, and strong customer service. Its primary customers include healthcare professionals and patients dealing with musculoskeletal pain related to knee OA. In late 2021, OrthogenRx entered an agreement to be acquired by Avanos Medical, Inc., which is expected to enhance Avanos’s chronic pain portfolio and expand treatment options for knee OA patients. This acquisition highlights OrthogenRx’s significance in the orthopedic medical device market and its commitment to musculoskeletal pain management.

• Employees 27
• Founded 2012
• Annual Revenue $7000000
• Total Funding $1216000